TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
UroMedical PS AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
44,673
|
42,502
|
36,100 |
Financial expenses |
59
|
34
|
5 |
Earnings before taxes |
16,243
|
20,055
|
17,243 |
EBITDA |
15,355
|
16,954
|
14,454 |
Total assets |
72,417
|
69,673
|
49,689 |
Current assets |
72,240
|
69,289
|
48,612 |
Current liabilities |
22,841
|
18,201
|
5,009 |
Equity capital |
46,655
|
48,134
|
41,123 |
- share capital |
100
![]() |
100
![]() |
100 |
Employees (average) |
12
![]() |
12
|
11 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
64.4%
|
69.1%
|
82.8% |
Turnover per employee |
3,723
|
3,542
|
3,282 |
Profit as a percentage of turnover |
36.4%
|
47.2%
|
47.8% |
Return on assets (ROA) |
22.5%
|
28.8%
|
34.7% |
Current ratio |
316.3%
|
380.7%
|
970.5% |
Return on equity (ROE) |
34.8%
|
41.7%
|
41.9% |
Change turnover |
2,171
|
6,402
|
14,091 |
Change turnover % |
5%
|
18%
|
64% |
Chg. No. of employees |
0
|
1
|
-2 |
Chg. No. of employees % |
0%
|
9%
|
-15% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.